Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

15-966 - Konrad et al v. AbbVie, Inc. et al


Download Files

Metadata

Document in Context
15-966 - Konrad et al v. AbbVie, Inc. et al
May 29, 2017
PDF | More
MDL CASE MANAGEMENT ORDER NO. 59 (rulings on omnibus motions in limine in AbbVie bellwether cases and case-specific motions in limine in Konrad v. AbbVie, Inc., Case No. 15 C 966 and Mitchell v. AbbVie, Inc., Case No. 14 C 9178), signed by the Honorable Matthew F. Kennelly on 5/29/2017. (mk)
October 3, 2017
PDF | More
MOTION by Defendants AbbVie, Inc., Abbott Laboratories, Inc. for judgment as a Matter of Law Pursuant to Federal Rule of Civil Procedure 50(A), and Memorandum in Support (Yeary, Michelle)
November 2, 2017
PDF | More
MOTION by Defendants AbbVie, Inc., Abbott Laboratories, Inc. for judgment as a Matter of Law, or Alternatively for a New Trial or Remittitur, and Memorandum in Support (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Yeary, Michelle)
July 5, 2018
PDF | More
MDL CASE MANAGEMENT ORDER NO. 129 (Memorandum Opinion and Order on post-trialmotions in Konrad v. AbbVie, No. 15 C 966), signed by the Honorable Matthew F. Kennelly on 7/5/2018: For the reasons stated in the accompanying Memorandum Opinion and Ordern the fall of this year (October, November, or December 2018) on a specific date to be set after discussion with counsel. (mk), the Court denies AbbVie's motion for judgment as a matter of law but grants its motion for a new trial [dkt. no. 118]. The Court vacates the judgment entered on October 5, 2017 and orders a new trial on all claims. The case will be retried i